Joon Lee
Stock Analyst at Truist Securities
(4.85)
# 82
Out of 5,241 analysts
116
Total ratings
65.22%
Success rate
51.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $490 → $525 | $436.95 | +20.15% | 5 | Mar 11, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $500 → $700 | $342.58 | +104.33% | 8 | Feb 20, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $228.77 | +0.54% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $799.32 | +28.86% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $51.81 | +93.01% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $6.77 | +638.55% | 4 | Dec 15, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $37.48 | +46.74% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $13.67 | +2.41% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $25.00 | +260.00% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $37.07 | +18.69% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $71.47 | +20.33% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $30.27 | +147.77% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $9.08 | +131.28% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $56.37 | +166.10% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $227.72 | -12.17% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $48.41 | +147.88% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.58 | +402.79% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.92 | +131.21% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $31.18 | +15.46% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.62 | +205.34% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $7.55 | +125.17% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.96 | -16.11% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.77 | +378.09% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $3.12 | +8,874.36% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $63.15 | -46.16% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Mar 11, 2026
Maintains: Buy
Price Target: $490 → $525
Current: $436.95
Upside: +20.15%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Buy
Price Target: $500 → $700
Current: $342.58
Upside: +104.33%
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $228.77
Upside: +0.54%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $799.32
Upside: +28.86%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $51.81
Upside: +93.01%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $6.77
Upside: +638.55%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $37.48
Upside: +46.74%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $13.67
Upside: +2.41%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $25.00
Upside: +260.00%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $37.07
Upside: +18.69%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $71.47
Upside: +20.33%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $30.27
Upside: +147.77%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $9.08
Upside: +131.28%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $56.37
Upside: +166.10%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $227.72
Upside: -12.17%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $48.41
Upside: +147.88%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.58
Upside: +402.79%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.92
Upside: +131.21%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $31.18
Upside: +15.46%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.62
Upside: +205.34%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.55
Upside: +125.17%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.96
Upside: -16.11%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.77
Upside: +378.09%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $3.12
Upside: +8,874.36%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $63.15
Upside: -46.16%